Spinal cord degeneration in C57BL/6N mice following induction of experimental parkinsonism with MPTP.
Level 5 - mechanism / opinion, no new human data
Animal model and in vitro laboratory study (non-clinical research).
PubMed 18036149 · doi:10.1111/j.1471-4159.2007.05091.x
What was done
Researchers evaluated whether the neurotoxin MPTP affects the spinal cord (SC) in C57BL/6N mice. Following intraperitoneal MPTP administration (single 25 mg/kg dose, or 2 x 25 mg/kg spaced 6 hours apart), HPLC-photodiode array analysis was used to measure MPP+ levels in the SC. In vivo and in vitro SC mitochondrial conversion of MPTP to MPP+ was tested with and without the MAO-B inhibitor l-deprenyl. Spinal cord tissues were assessed for MAO-B expression and activity (via immunofluorescence and kynuramine oxidation spectrofluorimetry), dopamine transporter localization, [3H]-MPP+ synaptosomal uptake, and neuronal cell death on day 7 post-treatment compared to controls.
What was found
MPP+ was detected in the SC after MPTP injection. In vitro conversion of MPTP to MPP+ by SC mitochondria was demonstrated and prevented by l-deprenyl. MAO-B expression, MAO-B enzymatic activity, and dopamine transporter immunoreactivity were confirmed in SC neurons, and synaptosomal preparations demonstrated specific [3H]-MPP+ uptake. On day 7 following MPTP treatment, SC neuronal death was increased relative to control animals. The abstract reports no quantitative values, percentages, or confidence intervals.
Why it matters
The study establishes that MPTP is locally metabolized into MPP+ within the spinal cord, leading to extra-nigral neuronal loss in an experimental model of Parkinson's disease. This suggests that spinal pathology may occur alongside or precede nigrostriatal neurodegeneration.
Limits
This was an animal and in vitro study using a chemical toxin model (MPTP), which does not fully capture idiopathic human Parkinson's disease etiology. The abstract does not disclose the sample size (n) of animals used, nor does it provide quantitative effect sizes, variance measures, or statistical test details for the reported neuronal death and biochemical assays. Long-term functional motor outcomes were not detailed.
Cited by
- supports MPTP is converted into toxic MPP+ by monoamine oxidase B, and MPP+ is selectively transported into dopaminergic neurons of the substantia nigra via the dopamine transporter.